Providing evidence-based information in a practical, easy-to-read format for practicing clinicians, investigators, industry scientists, and other entities involved in the field of neuroscience
Current Issue • January–March 2024
Letter to the Editor: Responding to commentary: addressing points raised in the correspondence about “ChatGPT and Transcranial Direct Current Stimulation for Chronic Pain”
Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. The authors have no conflicts of interest relevant to the contents of this letter. No funding was received for the preparation of this letter. Dear Editor: It was with [...]
Letter to the Editor: Response to “ChatGPT and Transcranial Direct Current Stimulation for Chronic Pain”
Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. The authors have no conflicts of interest relevant to the contents of this letter. No funding was received for the preparation of this letter. Dear Editor: We would like [...]
Letter to the Editor: Responding to correspondence on “Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes”
Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. Dr. Citrome is a consultant for AbbVie/Allergan, Acadia, Adamas, Alkermes, Angelini, Astellas, Avanir, Axsome, BioXcel, Boehringer Ingelheim, Cadent Therapeutics, Cerevel, Clinilabs, COMPASS, Eisai, Enteris BioPharma, HLS Therapeutics, Idorsia, INmune [...]
Letter to the Editor: Response to “Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes”
Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. Dr. Zaragoza Domingo is co-author and intellectual property owner of the EPICOG-SCH battery. No funding was received for the preparation of this letter. Dear Editor: As co-author of the [...]
Compulsive Biting and Chewing with Mixed Amphetamine Salts: A Case Report
by Melissa Free, MD; Hena Choi, BA; and Ritika Baweja, MD Drs. Free and Baweja are with Department of Psychiatry and Behavioral Health, Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania. Ms. [...]
How Should Therapists Treat Patients who are so Altruistic They Regularly Harm Themselves for the Sake of Others?
by Edmund Howe, MD, JD Dr. Howe is Professor of Psychiatry and Professor of Medicine, Uniformed Services University of the Health Sciences in Bethesda, Maryland. Department Editor: Julie P. Gentile, MD, is Professor and Chair [...]
Urdu Adaptation and Validation of Social Interaction Anxiety Scale: A Confirmatory Factor Analysis
by Uzma Ilyas, PhD scholar, and Prof. Dr. Saima Dawood, PhD Ms. Ilyas is Principal Lecturer, University of Central Punjab in Lahore, Pakistan. Prof. Dr. Daima is Director, Centre for Clinical Psychology, University of the [...]
GLP-1 Agonists Can Affect Mood: A Case of Worsened Depression on Ozempic (Semaglutide)
by Senthil Vel Rajan Rajaram Manoharan, MD, and Rohit Madan, MD Dr. Manoharan is with Huntsville Hospital/University of Alabama at Birmingham – Huntsville Campus in Huntsville, Alabama. Dr. Madan is with University of Arizona College [...]
Past Articles
Letter to the Editor: The Catastrophic Perception of Pain in Burning Mouth Syndrome May be Associated with Sympathetic Tone as Indicated by the QTc Interval
Innov Clin Neurosci. 2024;21(1–3):8–9. Funding/financial disclosures. The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Dear Editor: Unexplained somatic symptoms [...]
Artificial Intelligence and Neurorehabilitation: Fact vs. Fiction
by Nicola Fiorente, MD; Sepehr Mojdehdehbaher, BSc; and Rocco Salvatore Calabrò, MD, PhD Dr. Fiorente is with Polimedica Fisio and Sport in Cittadella (PD), Italy. Dr. Mojdehdehbaher is with Engineering Department, University of Messina in [...]
Impact of COVID-19 Pandemic on Patients with Serious Mental Illness (SMI) and Nonpsychiatric Control Subjects in Clinical Trials
by Maria Fe Garcia-Rada, MPS, and Robert E. Litman, MD Ms. Fe Garcia-Rada and Dr. Litman are with CenExel CBH Health in Gaithersburg, Maryland. Dr. Litman is additionally with Georgetown University Medical School in Washington, [...]
Current and Emerging Technologies to Address the Placebo Response Challenge in CNS Clinical Trials: Promise, Pitfalls, and Pathways Forward
by William P. Horan, PhD; Gary Sachs, MD; Dawn I. Velligan, PhD; Michael Davis, MD, PhD; Richard S.E. Keefe, PhD; Ni A. Khin, MD; Florence Butlen-Ducuing, MD, PhD; and Philip D. Harvey, PhD Dr. Horan [...]
Health Anxiety, Fear of COVID-19, Nosophobia, and Health-protective Behaviors Among Healthcare Professionals
by Uzma Ilyas, PhD scholar; Farwa Aslam, MS; Muqadas Fatima, MS; Zarmin Tariq, MS; and Prof Dr. Usman Hotiana, MBBS, FCPS (Psychology) Ms. Ilyas is Principal Lecturer, Psychology Department, University of Central Punjab in Lahore, [...]
Psychotherapy’s Role in Evaluating the Invisible Wounds of Moral Injury
by Ben Onnink, MD; Matthew C. Correll, BS Candidate; Andrew Correll, BS, MD Candidate; and Terry Correll, DO Dr. Onnink is a resident, Department of Psychiatry, Wright State University Boonshoft School of Medicine in Dayton, [...]
Functioning and Cognition in Patients with Schizophrenia After Initiating Treatment with Aripiprazole Lauroxil: Secondary Outcomes and Post Hoc Analysis
by Mark G. A. Opler, PhD, MPH; Amy Claxton, PhD*; James McGrory, PhD; Sabina Gasper, MPH*; Meihua Wang, PhD*; and Sergey Yagoda, MD, PhD Dr. Opler is with WCG, Inc. in New York, New York. [...]
Ensuring Stakeholder Feedback in the Design and Conduct of Clinical Trials for Rare Diseases: ISCTM Position Paper of the Orphan Disease Working Group
by Gahan J. Pandina, PhD; Joan Busner, PhD; Lucas Kempf, MD; Joan Fallon, BS, DC; Larry D. Alphs, MD, PhD; Maria T. Acosta, MD; Anna-Karin Berger, PhD; Simon Day, PhD; Judith Dunn, PhD; Victoria Villalta-Gil, [...]